Therapeutic drug monitoring in the neurocritical care unit
Authors:
- Vincent H MabasaVMVincent H Mabasa
- Mary Hh EnsomMEMary Hh Ensom
- 1 April 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 16 (2) , 128-135
Abstract
Various antiepileptics, sedative and anesthetic agents are used in the neurocritical care setting and therapeutic drug monitoring (TDM) has been proposed as a means to individualize dosing to ensure efficacy, avoid toxicity, and to account for drug-drug interactions. The purpose of this review is to highlight key articles relating to TDM published in the last 5 years with a focus on drug therapy for seizures, status epilepticus, and traumatic brain injury. Current evidence supports TDM of first-generation antiepileptics, and free-level monitoring for phenytoin and valproic acid is recommended in the neurocritical care population. There are insufficient data to recommend routine TDM of second-generation antiepileptics at this time. In traumatic brain injury, routine TDM of barbiturate infusions appears to be of little value in guiding or evaluating patient response to therapy except to differentiate between drug-induced coma and brain death. Although TDM of sedative agents has been studied, the use of clinical sedation scales is preferred over TDM in evaluating a patient's level of sedation. Therapeutic drug monitoring plays an important role in the care of patients in the neurocritical care setting but is applicable only to a limited number of drugs.Keywords
This publication has 28 references indexed in Scilit:
- A Critical Review: Does Thiopental Continuous Infusion Warrant Therapeutic Drug Monitoring in the Critical Care Population?Therapeutic Drug Monitoring, 2009
- Therapeutic Drug Monitoring of Phenytoin in Critically Ill PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- A Prospective Evaluation of Propylene Glycol Clearance and Accumulation During Continuous-Infusion Lorazepam in Critically Ill PatientsJournal of Intensive Care Medicine, 2008
- Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Targeted Therapy of Antiepileptic DrugsTherapeutic Drug Monitoring, 2008
- Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero lineClinical Chemistry and Laboratory Medicine (CCLM), 2008
- Does Oxcarbazepine Warrant Therapeutic Drug Monitoring?Clinical Pharmacokinetics, 2008
- Clinical Pharmacokinetic Monitoring of Midazolam in Critically Ill PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Fast, Simple, and Validated Gas Chromatographic-Mass Spectrometric Assay for Quantification of Drugs Relevant to Diagnosis of Brain Death in Human Blood Plasma SamplesTherapeutic Drug Monitoring, 2005
- Clinical Pharmacokinetics in the 21st CenturyClinical Pharmacokinetics, 1998